Global Non-Infectious Macular Edema Treatment Strategic Business Report 2022: 46 Companies Featured Including AbbVie, Alimera Sciences, Allergan and Amgen – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Non-Infectious Macular Edema Treatment: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Non-Infectious Macular Edema Treatment estimated at US$12.7 Billion in the year 2020, is projected to reach a revised size of US$18.6 Billion by 2027, growing at a CAGR of 5.6% over the analysis period 2020-2027. Anti-VEGF, one of the segments analyzed in the report, is projected to record a 5.3% CAGR and reach